Free Trial

UBS Group's Rating of Pfizer on 11/4/2026

On November 4, 2026, UBS Group updated its outlook on Pfizer (NYSE:PFE) with the action "Boost Price Target", setting a price target of $30.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from UBS Group AG

DateCompanyAction
11/4/2026
3M Company stock logo
MMM
3M
Set Price Target
11/4/2026
Flywire Corporation stock logo
FLYW
Flywire
Boost Price Target
11/4/2026
Arista Networks, Inc. stock logo
ANET
Arista Networks
Reiterated Rating
11/4/2026
Advanced Micro Devices, Inc. stock logo
AMD
Advanced Micro Devices
Lower Price Target
11/4/2026
Astera Labs, Inc. stock logo
ALAB
Astera Labs
Lower Price Target
11/4/2026
Duolingo, Inc. stock logo
DUOL
Duolingo
Boost Price Target
More Ratings From UBS Group AG